| Old Articles: <Older 9101-9110 Newer> |
|---|
 |
Chemistry World
June 8, 2015
Maria Burke |
Warnings that proposed UK blanket ban on 'legal highs' casts net too wide Some legal experts and scientists are warning that a proposed blanket ban on so-called 'legal highs' won't tackle the problem and may well hold back research into areas such as neuroscience.   |
Chemistry World
June 5, 2015
Rebecca Trager |
BMS sues executive for joining rival company Bristol-Myers Squibb has filed a lawsuit against a former executive who quit suddenly last month to work for a direct competitor, AstraZeneca. |
Chemistry World
June 4, 2015
Phillip Broadwith |
Takeda to consolidate vaccines business in Boston Japanese pharma firm Takeda plans to close three US sites and move the headquarters of its vaccines business unit to the pharmaceutical hub in the Boston and Cambridge area of Massachusetts. |
Chemistry World
June 3, 2015
Katrina Kramer |
Drugged: the science and culture behind psychotropic drugs Richard Miller, a pharmacology researcher at Northwestern University, US, and a medical humanities and bioethics professor, has written his first popular science book on the chemistry and culture of psychoactive compounds. |
Chemistry World
June 1, 2015
Phillip Broadwith |
Teva fined $1.2bn in pay-for-delay case Israeli firm Teva has reached a settlement with the US Federal Trade Commission over allegations of cutting illegal deals with generic drugmakers to stifle competition for sleep disorder drug Provigil (modafinil). |
Chemistry World
May 29, 2015
Emma Stoye |
UK launches universal ban on legal highs New laws banning the sale and distribution of all legal highs -- or new psychoactive substances -- have been drafted by the UK government. |
Chemistry World
May 29, 2015
Phillip Broadwith |
Achillion partners with Janssen to boost hepatitis C pipeline Janssen will invest $225 million in Achillion shares, and has promised performance milestone payments worth up to $1.1 billion, plus royalties on any sales. |
Chemistry World
May 27, 2015
Phillip Broadwith |
Actavis plan to thwart generics blocked A US court has blocked Ireland-based firm Actavis's attempt to forcibly shift patients onto an extended release version of one of its drugs by withdrawing the original formulation from the market. |
Chemistry World
May 27, 2015 |
US targets neonicotinoid use in pollinator plan The White House has unveiled a strategy to promote the health of honey bees and other pollinators that aims to revisit neonicotinoid insecticide use. |
Chemistry World
May 27, 2015
Phillip Broadwith |
Label laundry It's been an interesting month in the world of off-label pharmaceuticals. |
| <Older 9101-9110 Newer> Return to current articles. |
